73 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 11602059 | [The effect of p53 gene on p-glycoprotein expression and chemotherapeutic cytotoxicity of hepatocellular carcinoma]. | 2001 Aug | 1 |
52 | 11706756 | The potential clinical value of GML and the p53 gene as a predictor of chemosensitivity for colorectal cancer. | 2001 Apr | 3 |
53 | 10699952 | UCN-01 selectively enhances mitomycin C cytotoxicity in p53 defective cells which is mediated through S and/or G(2) checkpoint abrogation. | 2000 Mar 1 | 5 |
54 | 10741907 | Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro. | 2000 Mar | 1 |
55 | 10760566 | P53 tumour suppressor modulates transcription of the TATA-less gene coding for the tumour-associated carbonic anhydrase MN/CA IX in MaTu cells. | 2000 Apr 25 | 1 |
56 | 10842327 | Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation. | 2000 May | 1 |
57 | 10884389 | Repression of BRCA1 through a feedback loop involving p53. | 2000 Oct 13 | 1 |
58 | 10189126 | Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. | 1999 Mar 15 | 1 |
59 | 9506540 | Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells. | 1998 Mar 16 | 1 |
60 | 9212237 | Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53. | 1997 Jul 3 | 2 |
61 | 9285062 | The transcriptional repression of the human Cu/Zn superoxide dismutase(sod1) gene by the anticancer drug, mitomycin C(MMC). | 1997 Aug | 1 |
62 | 8639538 | Modulation of DNA topoisomerase I activity by p53. | 1996 May 7 | 1 |
63 | 8704210 | The effect of the Fanconi anemia polypeptide, FAC, upon p53 induction and G2 checkpoint regulation. | 1996 Aug 1 | 1 |
64 | 8707413 | In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug. | 1996 Jul 29 | 2 |
65 | 8945622 | Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations. | 1996 Nov 15 | 2 |
66 | 7478558 | Enhanced p53 activity and accumulation in response to DNA damage upon DNA transfection. | 1995 Oct 5 | 2 |
67 | 7623839 | Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression. | 1995 Aug | 3 |
68 | 7644500 | The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage. | 1995 Aug 15 | 2 |
69 | 7750085 | Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters. | 1995 May 4 | 1 |
70 | 7824283 | p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. | 1995 Jan 5 | 1 |
71 | 7896881 | p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. | 1995 Mar | 2 |
72 | 8084605 | p56/p53lyn tyrosine kinase activation in mammalian cells treated with mitomycin C. | 1994 Oct | 1 |
73 | 8485705 | Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. | 1993 May 15 | 1 |